• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用猫免疫缺陷病毒跨膜糖蛋白的一种肽进行免疫接种后出现的延迟感染。

Delayed infection after immunization with a peptide from the transmembrane glycoprotein of the feline immunodeficiency virus.

作者信息

Richardson J, Moraillon A, Crespeau F, Baud S, Sonigo P, Pancino G

机构信息

Génétique des Virus (ICGM-CNRS UPR 0415), Institut Cochin de Génétique Moléculaire, Paris, France.

出版信息

J Virol. 1998 Mar;72(3):2406-15. doi: 10.1128/JVI.72.3.2406-2415.1998.

DOI:10.1128/JVI.72.3.2406-2415.1998
PMID:9499101
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC109540/
Abstract

Recent advances in the quantitative assessment of viral burden, by permitting the extension of criteria applied to assess the efficacy of vaccines from all-or-none protection to diminution of the viral burden, may allow the identification of original immunogens of value in combined vaccines. Peptides corresponding to three domains of the envelope glycoproteins of feline immunodeficiency virus that are recognized during natural infection were used to immunize cats. After challenge with a primary isolate of feline immunodeficiency virus, the development of acute infection was monitored by quantitative assessment of the viral burden in plasma and tissues by competitive reverse transcription-PCR, by measurement of the humoral response developed to viral components, and by lymphocyte subset analysis. Whereas immunization with two peptides derived from the surface glycoprotein had no effect on the early course of infection, immunization with a peptide derived from the transmembrane glycoprotein delayed infection, as reflected by a diminished viral burden in the early phase of primary infection and delayed seroconversion. This peptide, located in the membrane-proximal region of the extracellular domain, has homology to an epitope of human immunodeficiency virus type 1 recognized by a broadly neutralizing monoclonal antibody. These results suggest that lentivirus transmembrane glycoproteins share a determinant in the juxtamembrane ectodomain which could be of importance in the design of vaccines against AIDS.

摘要

病毒载量定量评估方面的最新进展,通过允许将用于评估疫苗效力的标准从全或无保护扩展到病毒载量的减少,可能有助于识别联合疫苗中有价值的原始免疫原。使用与猫免疫缺陷病毒包膜糖蛋白三个结构域相对应的肽来免疫猫,这些结构域在自然感染期间会被识别。在用猫免疫缺陷病毒的原始分离株进行攻击后,通过竞争性逆转录聚合酶链反应对血浆和组织中的病毒载量进行定量评估、测量针对病毒成分产生的体液反应以及进行淋巴细胞亚群分析,来监测急性感染的发展。虽然用源自表面糖蛋白的两种肽进行免疫对感染的早期进程没有影响,但用源自跨膜糖蛋白的一种肽进行免疫延迟了感染,这在原发性感染的早期阶段病毒载量减少和血清转化延迟中得到体现。这种肽位于细胞外结构域的膜近端区域,与被一种广泛中和单克隆抗体识别的1型人类免疫缺陷病毒的一个表位具有同源性。这些结果表明,慢病毒跨膜糖蛋白在近膜胞外结构域共享一个决定簇,这在抗艾滋病疫苗的设计中可能很重要。

相似文献

1
Delayed infection after immunization with a peptide from the transmembrane glycoprotein of the feline immunodeficiency virus.用猫免疫缺陷病毒跨膜糖蛋白的一种肽进行免疫接种后出现的延迟感染。
J Virol. 1998 Mar;72(3):2406-15. doi: 10.1128/JVI.72.3.2406-2415.1998.
2
Dissection of seroreactivity against the tryptophan-rich motif of the feline immunodeficiency virus transmembrane glycoprotein.针对猫免疫缺陷病毒跨膜糖蛋白富含色氨酸基序的血清反应性剖析。
Virology. 2004 May 1;322(2):360-9. doi: 10.1016/j.virol.2004.02.017.
3
Targeted lymph node immunization can protect cats from a mucosal challenge with feline immunodeficiency virus.靶向淋巴结免疫可保护猫免受猫免疫缺陷病毒的黏膜攻击。
Vaccine. 2001 Oct 12;20(1-2):49-58. doi: 10.1016/s0264-410x(01)00323-1.
4
Vaccination with a feline immunodeficiency virus multiepitopic peptide induces cell-mediated and humoral immune responses in cats, but does not confer protection.用猫免疫缺陷病毒多表位肽进行疫苗接种可在猫体内诱导细胞介导的免疫反应和体液免疫反应,但不能提供保护。
J Virol. 1997 Oct;71(10):7586-92. doi: 10.1128/JVI.71.10.7586-7592.1997.
5
Protection against FIV challenge infection by genetic vaccination using minimalistic DNA constructs for FIV env gene and feline IL-12 expression.使用针对猫免疫缺陷病毒(FIV)包膜基因和猫白细胞介素-12表达的简约DNA构建体进行基因疫苗接种,以预防FIV攻击感染。
AIDS. 2000 Aug 18;14(12):1749-57. doi: 10.1097/00002030-200008180-00009.
6
Induction of feline immunodeficiency virus-specific cell-mediated and humoral immune responses following immunization with a multiple antigenic peptide from the envelope V3 domain.用来自包膜V3结构域的多抗原肽免疫后诱导猫免疫缺陷病毒特异性细胞介导和体液免疫反应
Immunology. 1995 Jun;85(2):171-5.
7
Partial protection by vaccination with recombinant feline immunodeficiency virus surface glycoproteins.用重组猫免疫缺陷病毒表面糖蛋白进行疫苗接种提供的部分保护作用。
AIDS Res Hum Retroviruses. 1998 Feb 10;14(3):275-83. doi: 10.1089/aid.1998.14.275.
8
A neutralizing antibody-inducing peptide of the V3 domain of feline immunodeficiency virus envelope glycoprotein does not induce protective immunity.猫免疫缺陷病毒包膜糖蛋白V3结构域的一种诱导中和抗体的肽不能诱导保护性免疫。
J Virol. 1994 Dec;68(12):8374-9. doi: 10.1128/JVI.68.12.8374-8379.1994.
9
Immunization-induced decrease of the CD4+:CD8+ ratio in cats experimentally infected with feline immunodeficiency virus.在实验性感染猫免疫缺陷病毒的猫中,免疫诱导的CD4⁺:CD8⁺比值降低。
Vet Immunol Immunopathol. 1992 Dec;35(1-2):199-214. doi: 10.1016/0165-2427(92)90132-a.
10
Env-expressing autologous T lymphocytes induce neutralizing antibody and afford marked protection against feline immunodeficiency virus.表达Env 的自体 T 淋巴细胞诱导中和抗体,并对猫免疫缺陷病毒提供显著保护。
J Virol. 2010 Apr;84(8):3845-56. doi: 10.1128/JVI.02638-09. Epub 2010 Feb 3.

引用本文的文献

1
Feline immunodeficiency virus model for designing HIV/AIDS vaccines.用于设计艾滋病毒/艾滋病疫苗的猫免疫缺陷病毒模型。
Curr HIV Res. 2010 Jan;8(1):14-25. doi: 10.2174/157016210790416361.
2
Antibodies generated in cats by a lipopeptide reproducing the membrane-proximal external region of the feline immunodeficiency virus transmembrane enhance virus infectivity.一种脂肽在猫体内产生的抗体可重现猫免疫缺陷病毒跨膜蛋白膜近端外部区域,该抗体增强了病毒的感染性。
Clin Vaccine Immunol. 2007 Aug;14(8):944-51. doi: 10.1128/CVI.00140-07. Epub 2007 Jun 27.
3
Antiviral activity and conformational features of an octapeptide derived from the membrane-proximal ectodomain of the feline immunodeficiency virus transmembrane glycoprotein.源自猫免疫缺陷病毒跨膜糖蛋白膜近端胞外域的八肽的抗病毒活性和构象特征
J Virol. 2003 Mar;77(6):3724-33. doi: 10.1128/jvi.77.6.3724-3733.2003.
4
Association of plasma viral RNA load with prognosis in cats naturally infected with feline immunodeficiency virus.猫免疫缺陷病毒自然感染猫的血浆病毒RNA载量与预后的关系
J Virol. 2002 Oct;76(19):10079-83. doi: 10.1128/jvi.76.19.10079-10083.2002.
5
Vaccine development against HIV-1: current perspectives and future directions.抗人类免疫缺陷病毒1型(HIV-1)疫苗的研发:现状与未来方向
Immunol Res. 2002;25(1):53-74. doi: 10.1385/ir:25:1:53.
6
During readaptation in vivo, a tissue culture-adapted strain of feline immunodeficiency virus reverts to broad neutralization resistance at different times in individual hosts but through changes at the same position of the surface glycoprotein.在体内重新适应过程中,一种适应组织培养的猫免疫缺陷病毒株在个体宿主的不同时间恢复为广泛中和抗性,但通过表面糖蛋白相同位置的变化实现。
J Virol. 2001 May;75(10):4584-93. doi: 10.1128/JVI.75.10.4584-4593.2001.
7
Expanded host cell tropism and cytopathic properties of feline immunodeficiency virus strain PPR subsequent to passage through interleukin-2-independent T cells.猫免疫缺陷病毒PPR株在通过白介素-2非依赖型T细胞传代后的宿主细胞嗜性扩展及细胞病变特性
J Virol. 2000 Feb;74(4):1854-63. doi: 10.1128/jvi.74.4.1854-1863.2000.
8
Kinetics of replication of a partially attenuated virus and of the challenge virus during a three-year intersubtype feline immunodeficiency virus superinfection experiment in cats.在一项为期三年的猫科动物不同亚型猫免疫缺陷病毒重复感染实验中,部分减毒病毒与攻击病毒的复制动力学。
J Virol. 1999 Feb;73(2):1518-27. doi: 10.1128/JVI.73.2.1518-1527.1999.
9
AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: detailed analysis of the humoral immune response to a protective vaccine.使用体外猫免疫缺陷病毒模型的艾滋病疫苗研究:对一种保护性疫苗的体液免疫反应的详细分析。
J Virol. 1999 Jan;73(1):1-10. doi: 10.1128/JVI.73.1.1-10.1999.

本文引用的文献

1
Enhancement of feline immunodeficiency virus (FIV) infection after DNA vaccination with the FIV envelope.用猫免疫缺陷病毒(FIV)包膜进行DNA疫苗接种后猫免疫缺陷病毒(FIV)感染的增强。
J Virol. 1997 Dec;71(12):9640-9. doi: 10.1128/JVI.71.12.9640-9649.1997.
2
Atomic structure of the ectodomain from HIV-1 gp41.来自HIV-1 gp41的胞外域的原子结构。
Nature. 1997 May 22;387(6631):426-30. doi: 10.1038/387426a0.
3
Core structure of gp41 from the HIV envelope glycoprotein.来自HIV包膜糖蛋白的gp41核心结构。
Cell. 1997 Apr 18;89(2):263-73. doi: 10.1016/s0092-8674(00)80205-6.
4
Role of complement and Fc receptors in the pathogenesis of HIV-1 infection.补体和Fc受体在HIV-1感染发病机制中的作用。
Springer Semin Immunopathol. 1997;18(3):371-90. doi: 10.1007/BF00813504.
5
Feline immunodeficiency virus vaccination: characterization of the immune correlates of protection.猫免疫缺陷病毒疫苗接种:保护性免疫相关因素的特征分析
J Virol. 1996 Nov;70(11):7561-8. doi: 10.1128/JVI.70.11.7561-7568.1996.
6
HIV-1 neutralization: the consequences of viral adaptation to growth on transformed T cells.HIV-1中和作用:病毒适应在转化T细胞上生长的后果。
AIDS. 1995;9 Suppl A:S117-36.
7
HIV-1-specific immunity in persistently seronegative individuals at high risk for HIV infection.处于HIV感染高风险的持续血清阴性个体中的HIV-1特异性免疫。
Immunol Lett. 1996 Jun;51(1-2):39-43. doi: 10.1016/0165-2478(96)02553-9.
8
The consequence of passive administration of an anti-human immunodeficiency virus type 1 neutralizing monoclonal antibody before challenge of chimpanzees with a primary virus isolate.在黑猩猩用一种原发性病毒分离株攻击之前被动给予抗1型人类免疫缺陷病毒中和单克隆抗体的后果。
J Virol. 1996 Oct;70(10):6751-8. doi: 10.1128/JVI.70.10.6751-6758.1996.
9
Suppression of virus burden by immunization with feline immunodeficiency virus Env protein.
Vaccine. 1996 Apr;14(5):405-11. doi: 10.1016/0264-410x(95)00193-5.
10
Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.包膜糖蛋白合成肽对猫免疫缺陷病毒体外感染的抑制作用
Virology. 1996 Jun 15;220(2):274-84. doi: 10.1006/viro.1996.0315.